Long-Term Cardiac Sequelae in Patients Referred into a Diagnostic Post-COVID-19 Pathway: The Different Impacts on the Right and Left Ventricles.

SARS-CoV-2 biventricular dysfunction cardiac involvement echocardiography long-COVID-19 pulmonary hypertension

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
06 Nov 2021
Historique:
received: 07 09 2021
revised: 29 10 2021
accepted: 03 11 2021
entrez: 27 11 2021
pubmed: 28 11 2021
medline: 28 11 2021
Statut: epublish

Résumé

Most patients who had COVID-19 are still symptomatic after many months post infection, but the long-term outcomes are not yet well defined. The aim of our prospective/retrospective study was to define the cardiac sequelae of COVID-19 infection. This monocentric cohort study included 160 consecutive patients who had been discharged from the ward or from the outpatient clinic after a diagnosis of COVID-19 and subsequently referred for a follow-up visit. Clinical features' data about the acute phase along with information about the follow-up visit, including ECG and Echocardiographic parameters, were recorded. At an average follow-up of 5 months, echocardiography showed morpho-functional characteristics of both right (RV) and left (LV) ventricles, such as RV dilation, increased pressure in the pulmonary circulation, and bi-ventricular systolic-diastolic dysfunction. When examined using multivariate analysis, independent of age, sex, and co-morbidities, RV and LV changes were significantly associated with chest High-Resolution computed tomography score and hemodynamic Instability (HI), and with C-reactive protein, respectively. Our results suggest that COVID-19 may impact RV and LV differently. Notably, the extent of the pneumonia and HI may affect RV, whereas the inflammatory status may influence LV. A long-term follow-up is warranted to refine and customize the most appropriate therapeutic strategies.

Identifiants

pubmed: 34829406
pii: diagnostics11112059
doi: 10.3390/diagnostics11112059
pmc: PMC8623572
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Circ Res. 2020 May 8;126(10):1443-1455
pubmed: 32252591
J Med Virol. 2021 Feb;93(2):1013-1022
pubmed: 32729939
Heart. 2020 Sep;106(17):1324-1331
pubmed: 32675217
Int J Cardiovasc Imaging. 2021 Jan;37(1):135-144
pubmed: 32803484
N Engl J Med. 2020 Jun 18;382(25):2478-2480
pubmed: 32302081
Thorax. 2021 Apr;76(4):405-407
pubmed: 33273028
Intensive Care Med. 2020 May;46(5):846-848
pubmed: 32125452
Circulation. 2020 Jul 28;142(4):342-353
pubmed: 32469253
JACC Case Rep. 2020 Jul 15;2(9):1414-1418
pubmed: 32835287
Eur Heart J. 2020 May 14;41(19):1861-1862
pubmed: 32267502
Lancet Reg Health Eur. 2021 Jul;6:100122
pubmed: 34027514
J Am Coll Cardiol. 2020 Oct 27;76(17):1965-1977
pubmed: 33092732
Eur J Heart Fail. 2020 May;22(5):911-915
pubmed: 32275347
JACC Basic Transl Sci. 2020 Apr 10;5(5):518-536
pubmed: 32292848
Cardiovasc Res. 2020 Aug 1;116(10):1666-1687
pubmed: 32352535
Eur Heart J. 2020 Jun 7;41(22):2070-2079
pubmed: 32391877
JAMA Cardiol. 2020 Jul 1;5(7):819-824
pubmed: 32219357
Echocardiography. 2020 Oct;37(10):1551-1556
pubmed: 32949015
Eur Respir J. 2018 Jan 31;51(2):
pubmed: 29386335
Int J Chron Obstruct Pulmon Dis. 2016 May 13;11:1015-22
pubmed: 27257378
JAMA. 2020 Aug 11;324(6):603-605
pubmed: 32644129
J Am Soc Echocardiogr. 2009 Feb;22(2):107-33
pubmed: 19187853
Respir Care. 2019 Jun;64(6):617-628
pubmed: 31110031
Eur Heart J. 2020 Oct 14;41(39):3827-3835
pubmed: 32968776
JACC Cardiovasc Imaging. 2020 Nov;13(11):2287-2299
pubmed: 32654963
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14
pubmed: 25559473
Pulm Circ. 2020 Jul 2;10(3):2045894020936660
pubmed: 32655856
Heart. 2020 Aug;106(15):1127-1131
pubmed: 32499236
High Blood Press Cardiovasc Prev. 2021 Sep;28(5):439-445
pubmed: 34173942
ERJ Open Res. 2020 Oct 26;6(4):
pubmed: 33257910

Auteurs

Giovanna Pelà (G)

Department of Medicine and Surgery, University of Parma, 43100 Parma, Italy.
Department of General and Specialistic Medicine, University-Hospital of Parma, 43100 Parma, Italy.

Matteo Goldoni (M)

Department of Medicine and Surgery, University of Parma, 43100 Parma, Italy.

Chiara Cavalli (C)

Department of Medicine and Surgery, University of Parma, 43100 Parma, Italy.

Felice Perrino (F)

Department of Medicine and Surgery, University of Parma, 43100 Parma, Italy.

Sara Tagliaferri (S)

Department of Medicine and Surgery, University of Parma, 43100 Parma, Italy.

Annalisa Frizzelli (A)

Department of Medicine and Surgery, University of Parma, 43100 Parma, Italy.
Respiratory Disease and Lung Function Unit, Cardio-Thoracic and Vascular Department, University-Hospital of Parma, 43100 Parma, Italy.

Pier Anselmo Mori (PA)

Pulmonology and Endoscopic Unit, Cardio-Thoracic and Vascular Department, University-Hospital of Parma, 43100 Parma, Italy.

Maria Majori (M)

Pulmonology and Endoscopic Unit, Cardio-Thoracic and Vascular Department, University-Hospital of Parma, 43100 Parma, Italy.

Marina Aiello (M)

Department of Medicine and Surgery, University of Parma, 43100 Parma, Italy.
Respiratory Disease and Lung Function Unit, Cardio-Thoracic and Vascular Department, University-Hospital of Parma, 43100 Parma, Italy.

Nicola Sverzellati (N)

Department of Medicine and Surgery, University of Parma, 43100 Parma, Italy.
Diagnostic Department, Radiological Sciences, University-Hospital of Parma, 43100 Parma, Italy.

Massimo Corradi (M)

Department of Medicine and Surgery, University of Parma, 43100 Parma, Italy.

Alfredo Chetta (A)

Department of Medicine and Surgery, University of Parma, 43100 Parma, Italy.
Respiratory Disease and Lung Function Unit, Cardio-Thoracic and Vascular Department, University-Hospital of Parma, 43100 Parma, Italy.

Classifications MeSH